Articles
Volume 5 (2005) - September 2005
|
Differential expression of MUC genes in endometrial and cervical tissues and tumors Vidya Hebbar, Gautam Damera, Goverdhan P Sachdev BMC Cancer 2005, 5:124 (27 September 2005) |
|
S Théoleyre, K Mori, B Cherrier, N Passuti, F Gouin, F Rédini, D Heymann BMC Cancer 2005, 5:123 (27 September 2005) |
|
Rimantas Eidukevicius, Dainius Characiejus, Ramunas Janavicius, Nijole Kazlauskaite, Vita Pasukoniene, Mykolas Mauricas, Willem Otter BMC Cancer 2005, 5:122 (22 September 2005) |
|
Michael Samoszuk, Emi Kanakubo, John K Chan BMC Cancer 2005, 5:121 (21 September 2005) |
|
Jean Boutonnat, Anne-Marie Faussat, Jean-Pierre Marie, Jérôme Bignon, Johanna Wdzieczak-Bakala, Magali Barbier, Josiane Thierry, Xavier Ronot, Pierre-Emmanuel Colle BMC Cancer 2005, 5:120 (20 September 2005) |
|
Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma Yen-Ching Lee, Janeanne R Perren, Evelyn L Douglas, Michael P Raynor, Maria A Bartley, Peter G Bardy, Sally-Anne Stephenson BMC Cancer 2005, 5:119 (20 September 2005) The EphB4 receptor tyrosine kinase is expressed in prostate cancer cell lines and over-expressed in prostate cancer tissues and should be considered as a potential target for anti-prostate cancer therapy.
|
|
Carlos Lopez-Graniel, Rigoberto Dolores, Lucely Cetina, Aaron Gonzalez, David Cantu, Jose Chanona, Jesus Uribe, Myrna Candelaria, Rocio Brom, Jaime de la Garza, Alfonso Duenas-Gonzalez BMC Cancer 2005, 5:118 (19 September 2005) |
|
Oral ulcer as an exclusive sign of gastric cancer: report of a rare case Piergiuseppe Colombo, Luca Tondulli, Giovanna Masci, Andrea Muzza, Lorenza Rimassa, Duccio Petrella, Armando Santoro BMC Cancer 2005, 5:117 (19 September 2005) |
|
Gregory D Leonard, Maurice A Wright, Mary G Quinn, Suzanne Fioravanti, Nancy Harold, Barbara Schuler, Rebecca R Thomas, Jean L Grem BMC Cancer 2005, 5:116 (16 September 2005) |
|
Simona Kranjc, Maja Cemazar, Alenka Grosel, Marjeta Sentjurc, Gregor Sersa BMC Cancer 2005, 5:115 (16 September 2005) |
|
Anthracyclines, proteasome activity and multi-drug-resistance Mirela R Fekete, William H McBride, Frank Pajonk BMC Cancer 2005, 5:114 (13 September 2005) Anthracyclines can act as inhibitors of the 26S proteasome and P-glycoprotein in vitro, and thus they are potential candidates for the control of chemoresistance during cancer therapy.
|
|
Victoria AL Tomlinson, Helen J Newbery, Naomi R Wray, Juliette Jackson, Alexey Larionov, William R Miller, J Michael Dixon, Catherine M Abbott BMC Cancer 2005, 5:113 (12 September 2005) The elongation factor eEF1A2 is abnormally expressed in two thirds of breast tumours and thus, it has the potential to become a new diagnostic marker or therapeutic target for breast cancer.
|
|
Family history of colorectal cancer in Iran Mahboobeh Mahdavinia, Faraz Bishehsari, Reza Ansari, Nasim Norouzbeigi, Ahmad Khaleghinejad, Mahshid Hormazdi, Naser Rakhshani, Reza Malekzadeh BMC Cancer 2005, 5:112 (5 September 2005) |
|
Maria Cardillo, Vincenzo Gentile, Mauro Ciccariello, Laura Giacomelli, Silvio Messinetti, Franco Di Silverio BMC Cancer 2005, 5:111 (5 September 2005) |